SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 3 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $965,000 | -67.7% | 86,200 | -71.7% | 0.00% | -71.4% |
| Q2 2017 | $2,989,000 | 0.0% | 305,073 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $2,989,000 | -9.3% | 305,073 | 0.0% | 0.01% | -22.2% |
| Q4 2016 | $3,294,000 | +5.4% | 305,073 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $3,126,000 | -21.5% | 305,073 | 0.0% | 0.02% | -25.0% |
| Q2 2016 | $3,984,000 | -12.1% | 305,073 | -26.0% | 0.02% | -17.2% |
| Q1 2016 | $4,533,000 | +19.6% | 412,166 | 0.0% | 0.03% | +11.5% |
| Q4 2015 | $3,791,000 | +32.6% | 412,166 | 0.0% | 0.03% | +23.8% |
| Q3 2015 | $2,860,000 | -18.9% | 412,166 | +14.7% | 0.02% | -16.0% |
| Q2 2015 | $3,527,000 | +14.0% | 359,240 | +2.8% | 0.02% | +8.7% |
| Q1 2015 | $3,095,000 | +56.2% | 349,390 | +54.4% | 0.02% | +43.8% |
| Q4 2014 | $1,982,000 | +527.2% | 226,280 | +296.7% | 0.02% | -52.9% |
| Q3 2012 | $316,000 | – | 57,035 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |